Tert-butyl N-[[4-(benzylamino)-2-(4-cyano-2-methylindol-1-yl)pyrimidin-5-yl]methyl]-N-methylcarbamate
C28H30N6O2 — CID 118152039
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[[4-(benzylamino)-2-(4-cyano-2-methylindol-1-yl)pyrimidin-5-yl]methyl]-N-methylcarbamate
Tert-butyl N-[[4-(benzylamino)-2-(4-cyano-2-methylindol-1-yl)pyrimidin-5-yl]methyl]-N-methylcarbamate (PubChem CID 118152039) has the molecular formula C28H30N6O2 and a molecular weight of 482.59 g/mol. Its IUPAC name is tert-butyl N-[[4-(benzylamino)-2-(4-cyano-2-methylindol-1-yl)pyrimidin-5-yl]methyl]-N-methylcarbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[[4-(benzylamino)-2-(4-cyano-2-methylindol-1-yl)pyrimidin-5-yl]methyl]-N-methylcarbamate |
|---|---|
| PubChem CID | 118152039 |
| Molecular Formula | C28H30N6O2 |
| Molecular Weight | 482.59 g/mol |
| Exact Mass | 482.24 |
| IUPAC Name | tert-butyl N-[[4-(benzylamino)-2-(4-cyano-2-methylindol-1-yl)pyrimidin-5-yl]methyl]-N-methylcarbamate |
| SMILES | Cc1cc2c(C#N)cccc2n1-c1ncc(CN(C)C(=O)OC(C)(C)C)c(NCc2ccccc2)n1 |
| InChI | InChI=1S/C28H30N6O2/c1-19-14-23-21(15-29)12-9-13-24(23)34(19)26-31-17-22(18-33(5)27(35)36-28(2,3)4)25(32-26)30-16-20-10-7-6-8-11-20/h6-14,17H,16,18H2,1-5H3,(H,30,31,32) |
| InChIKey | DIWCNIQQYORJAW-UHFFFAOYSA-N |
| XLogP | 5.58 |
| TPSA | 96.07 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 482.59 |
| LogP ≤ 5 | 5.58 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118152039 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.